Navigation Links
TonoPach

ProductsTonoPach
Company Neuvas, Inc.
Item TonoPach
Features The TonoPachs patented technology combines CCT and IOP in a single, inexpensive, easy-to-use instrument. The TonoPach has been designed to measure intraocular pressure in millions of patients who are presently improperly diagnosed for glaucoma and ocular hypertension.
Description The TonoPach is a device intended for highly accurate measurements of intraocular pressure (IOP). IOP remains the single most important metric for the diagnosis and treatment of glaucoma. However, as discovered in a large, randomized, five-year National Institute of Health (NIH) study published in mid-2002, the patients central cornea thickness (CCT) is an important and necessary biometric parameter in risk assessment for this patient population.
Info Neuvas, Inc.
Customer Service:
Web site: http://www.retinapharma.com

Related medicine products :

1. GonoGen™
... a rapid, real-time thermal cycler used for ... automating much of the testing process, and ... is the fastest, easiest to use, and ... The SmartCycler delivers highly accurate and consistent ...
... is a rapid, real-time thermal cycler used ... By automating much of the testing process, ... it is the fastest, easiest to use, ... market. The SmartCycler delivers highly accurate and ...
... The SmartCycler System is a rapid, ... from prepared biological samples. By automating much ... reaction site individually programmable, it is the ... system now on the market. The SmartCycler ...
... is a rapid, real-time thermal cycler used ... By automating much of the testing process, ... it is the fastest, easiest to use, ... market. The SmartCycler delivers highly accurate and ...
Medicine Products:
(Date:8/30/2014)... 2014 Ms. Meriwether’s striking beauty is not ... has an impressive resume to boost. Nana is best ... However, she’s also a two time All American UCLA ... trained for the 2008 Olympics and played professional volleyball as ... six-foot beauty from Potomac, Maryland is a two-time, All American ...
(Date:8/30/2014)... Tampa, FL (PRWEB) August 30, 2014 ... operated full service auto repair shop with strong ties to ... McLeod Family is happy to announce they have been chosen ... number one pick for auto repair. , Tim McLeod’s ... Park Auto Service sixty years ago. Although his son, Tim ...
(Date:8/30/2014)... As 500 Zoloft lawsuits pending ligation contend the ... mothers, Wright & Schulte LLC recently learned of a remand ... remand in the Zoloft lawsuits was granted to ... involved in one SSRI lawsuit filed jointly under ... defect lawsuit sent back to the Missouri state court in ...
(Date:8/30/2014)... Barton Associates, an industry leading national physician, physician ... announces a new office location in Austin, TX, scheduled ... in Peabody, MA, with additional staffing centers in Hardwick, ... , Barton Associates decided to expand its workforce ... The United States is in the midst of a ...
(Date:8/30/2014)... CT (PRWEB) August 30, 2014 ... national observance that educates Americans about the fact ... by recovery, from alcohol and drug addiction and ... organizations join with treatment providers, prevention programs and ... heals individuals, families, workplaces and neighborhoods. The ...
Breaking Medicine News(10 mins):Health News:NJ Top Dentists Announces Cover Model for the Healthy Living: Top Dentists Issue 2Health News:McLeod's Sunset Park Auto Service Celebrates 60 Years Honored with Best of South Tampa 2Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 2Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 3Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 4Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 5Health News:Barton Associates Announces New Office Location in Austin, TX 2Health News:September is National Recovery Month: What the Connecticut Community for Addiction Recovery (CCAR) Wants You to Know 2Health News:September is National Recovery Month: What the Connecticut Community for Addiction Recovery (CCAR) Wants You to Know 3
... high-tech, high-power men,s skincare ... exclusively at Barney,s, NEW YORK, April 16 The ... thousands of,products to meet their needs, now gives men some ... renowned men,s skincare line,steps it up with the introduction of ...
... 16 Abbott (NYSE:,ABT) announced today that it ... Labour and Welfare for HUMIRA(R) (adalimumab) for the,treatment ... to,conventional therapy. This approval is the first for ... HUMIRA with Eisai Co., Ltd. HUMIRA,is now approved ...
... Healthcare,Management Group, Inc. (Phyhealth) (Pink Sheets: PHYH), a ... physicians,today announced that it has filed with the ... December 31, 2005, December 31, 2006, and,the nine ... of filing its,historical financials, Phyhealth expects to be ...
... - Worldwide Sales Growth of 13.8 Percent - ... - Worldwide Medical Products Sales Increased 13.7 Percent - ... First Quarter -, ABBOTT PARK, Ill., April 16 Abbott (NYSE:,ABT) today ... * Diluted earnings per share, excluding specified items, were ...
... Ore. Oregon Health & Science University researchers have ... cells. , This finding is important because expression ... such as lymphoma and breast cancers, said Charles Lopez, ... of Medicine., The research will be presented at a ...
... 16 The Blackstone,Group has today informed us that ... in Gerresheimer AG, held by BCP Murano II S.a.r.l. ... by Credit Suisse, 7.8 million,shares will be sold to ... exit its Gerresheimer investment after Gerresheimer,s IPO,in June 2007. ...
Cached Medicine News:Health News:Mens Luxury Skincare Market Grows 2Health News:Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis 2Health News:Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis 3Health News:Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis 4Health News:Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis 5Health News:Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis 6Health News:Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis 7Health News:Phyhealth Files Historical Financials With the Pink Sheets and Takes Next Step Toward Becoming Fully Reporting 2Health News:Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook 2Health News:Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook 3Health News:Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook 4Health News:Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook 5Health News:Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook 6Health News:Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook 7Health News:Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook 8Health News:Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook 9Health News:Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook 10Health News:Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook 11Health News:Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook 12Health News:Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook 13Health News:Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook 14Health News:Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook 15Health News:Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook 16Health News:Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook 17Health News:Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook 18
(Date:8/29/2014)... SPRING, Md. , Aug. 29, 2014  United ... that the U.S. District Court for the District of ... its favor in the company,s case against Sandoz, Inc. ... Judge Peter Sheridan ruled that U.S. Patent ... Inc., and enjoined Sandoz from marketing its generic product ...
(Date:8/29/2014)... August 29, 2014 According ... Product & Services (Equipment, Reagent, Primer, Probe, Custom ... PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) - ... global Oligonucleotide Synthesis Market is expected to reach ... 2014, growing at a CAGR of 9.8% from ...
(Date:8/29/2014)... , Aug. 29, 2014  Unilife Corporation ("Unilife" or ... today that it intends to release its financial results ... June 30, 2014 after market trading ends on Tuesday, ... a conference call for 4:30 p.m. U.S. EDT on ... 6:30 a.m. AEST), to review the Company,s financial results, commercial ...
Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2